Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is N/A as of 2026-10-06T22:22:41.772Z.
Calculation as of: 2026-10-06T22:22:41.772Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 75157c8a62e3fe86a7e5d9b3960d4dd2a79ae28b02be5cac6a633fb547f90e56
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
N/A
Jyong Biotech Ltd. Ordinary Shares
Market Cap
$153.58M
PB Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jyong Biotech Ltd. Ordinary Shares (MENS) | $153.58M | N/A | N/A | N/A | N/A |
| Neuronetics, Inc. (STIM)vs › | $153.79M | 8.62 | 6.64 | 5.22 | 3.69 |
| Veraxa Biotech Holding AG (VRXA)vs › | $152.72M | N/A | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | 8.92 | 10.84 | 9.66 | 6.56 |
| Inogen, Inc. (INGN)vs › | $156.22M | 0.89 | 0.93 | 0.96 | 1.16 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | 1.10 | 2.06 | 1.70 | 1.69 |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | 29.24 | 1.48 | 1.03 | 1.17 |
| Voyager Therapeutics, Inc. (VYGR)vs › | $148.64M | 0.96 | 1.16 | 1.18 | 1.85 |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | 1.32 | 3.31 | 4.55 | 5.01 |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | 2.62 | 2.60 | 2.41 | 10.02 |
P/B Ratio
N/A
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
